Delivery Order SPE2DB20D1100-SPE2DB25FE0VS
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,113.19 to AmerisourceBergen Drug Corp for 10,000 units of chorionic gonadotropin (a hormone treatment) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price, non-set-aside contract represents a competitive award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 10,000 units of chorionic gonad with a ceiling value of $3,692.80. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed price terms, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $6,072.86 to AmerisourceBergen Drug Corp on June 25, 2025, with completion targeted for July 23, 2025. The award covers HCG MDV 10,000U 10ML in single-unit quantities under a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor. The contract represents a...
- This federal contract award, valued at $5,134.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 10,000 units of chorionic gonad, a medical product. The contract is not set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $30,760.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product used in fertility treatment. This non-set-aside award, issued on July 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,412.50 for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pregnyl 10,000 Unit Vials, a human chorionic gonadotropin pharmaceutical product. This firm fixed-price delivery order, valued at $1,813.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.50 to AmerisourceBergen Drug Corp for Pregnyl 10,000 unit vials, a human chorionic gonadotropin medication. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency has awarded a $17,991.54 delivery order to AmerisourceBergen Drug Corp for the supply of GONAL-F RFF REDI-JECT 900 Unit 1.5ML, a fertility medication, with a completion date of June 2, 2025. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $31,639.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product used in fertility treatment. The award, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a non-competitive delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...